Application of ultrasound combined with microbubbles in conversion therapy for advanced liver cancer
- 1Department of Ultrasound, Affiliated Hospital of Guangdong Medical University
- 2Department of Ultrasound, Huzhou Central Hospital
- 3Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University
Abstract
Ultrasound combined with microbubbles (USMB) at a low mechanical index has been shown to enhance blood perfusion and drug delivery, suggesting its potential to augment tumor immunotherapy. This study aims to evaluate whether the addition of USMB to conversion therapy can improve tumor response and local perfusion in patients with advanced hepatocellular carcinoma (HCC), while maintaining a comparable safety profile. This study enrolled 40 patients with unresectable advanced hepatocellular carcinoma (HCC) who underwent conversion therapy, including locoregional interventional therapy, targeted therapy, and immunotherapy. All patients underwent two contrast-enhanced ultrasound (CEUS) examinations after the conversion therapy to assess changes in perfusion. The experimental group (n = 16) received adjuvant ultrasound-mediated microbubble (USMB) treatment in the interval between the two examinations, whereas the control group (n = 24) did not. Following conversion therapy, the maximum diameter of the viable tumor in the combination treatment group n=16 was significantly smaller than that in the control group n=24 P=0.013 . Moreover, the reduction rate of the maximum viable tumor diameter was significantly greater in the combination treatment group P=0.006 . Although the combination group demonstrated a higher clinical benefit rate, no statistically significant difference in treatment response according to modified Response Evaluation Criteria in Solid Tumors (mRECIST) was observed between the two groups P=0.330 . In addition, CEUS evaluation showed an increase in the blood flow perfusion index in the combination group following ultrasound treatment. USMB can improve local blood flow perfusion in advanced liver cancer and may enhance the efficacy of conversion therapy without increasing treatment-related adverse effects.
Related
- Immune checkpoint inhibitors combined with VEGF/VEGFR-targeted therapy in microsatellite-stable advanced colorectal cancer: clinical advances and the potential for immune-sensitive tumor conversion
- Ultra-low contrast intravascular ultrasound-guided percutaneous coronary intervention of the left main and left anterior descending artery in advanced chronic kidney disease
- Core needle biopsy washout biomarkers combined with ultrasound for preoperative axillary risk stratification in breast cancer: a retrospective nomogram study with temporal validation
- Ultrasound-guided hydrodissection combined with radiofrequency for refractory occipital neuralgia: clinical outcomes, durability, and factors associated with repeat intervention
- Stepwise acupuncture exploration followed by ultrasound-guided needle-knife release combined with local infiltration for chronic intercostal muscle–related myofascial pain : A case report
BibTeX
@article{zhou2026application,
title = {{Application of ultrasound combined with microbubbles in conversion therapy for advanced liver cancer}},
author = {Honglian Zhou and Zexin Chen and Xinrong Zhong and Guojia Yuan and Yueqiong Zhou and Jiexin Wang and Xiaohong Xu},
journal = {Scientific Reports},
year = {2026},
month = jul,
doi = {10.1038/s41598-026-55992-x},
url = {https://doi.org/10.1038/s41598-026-55992-x},
note = {CC BY},
}
RIS
TY - JOUR
TI - Application of ultrasound combined with microbubbles in conversion therapy for advanced liver cancer
AU - Honglian Zhou
AU - Zexin Chen
AU - Xinrong Zhong
AU - Guojia Yuan
AU - Yueqiong Zhou
AU - Jiexin Wang
AU - Xiaohong Xu
PY - 2026
DA - 2026/07/01
JO - Scientific Reports
DO - 10.1038/s41598-026-55992-x
UR - https://doi.org/10.1038/s41598-026-55992-x
AB - Ultrasound combined with microbubbles (USMB) at a low mechanical index has been shown to enhance blood perfusion and drug delivery, suggesting its potential to augment tumor immunotherapy. This study aims to evaluate whether the addition of USMB to conversion therapy can improve tumor response and local perfusion in patients with advanced hepatocellular carcinoma (HCC), while maintaining a comparable safety profile. This study enrolled 40 patients with unresectable advanced hepatocellular carcinoma (HCC) who underwent conversion therapy, including locoregional interventional therapy, targeted therapy, and immunotherapy. All patients underwent two contrast-enhanced ultrasound (CEUS) examinations after the conversion therapy to assess changes in perfusion. The experimental group (n = 16) received adjuvant ultrasound-mediated microbubble (USMB) treatment in the interval between the two examinations, whereas the control group (n = 24) did not. Following conversion therapy, the maximum diameter of the viable tumor in the combination treatment group n=16 was significantly smaller than that in the control group n=24 P=0.013 . Moreover, the reduction rate of the maximum viable tumor diameter was significantly greater in the combination treatment group P=0.006 . Although the combination group demonstrated a higher clinical benefit rate, no statistically significant difference in treatment response according to modified Response Evaluation Criteria in Solid Tumors (mRECIST) was observed between the two groups P=0.330 . In addition, CEUS evaluation showed an increase in the blood flow perfusion index in the combination group following ultrasound treatment. USMB can improve local blood flow perfusion in advanced liver cancer and may enhance the efficacy of conversion therapy without increasing treatment-related adverse effects.
SN - 2045-2322
ER -